Bailard »

Inozyme Pharma shares owned by Bailard

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Bailard

Quarter filed Position value Share count Share price at filing
2024-09-30 $127k 24k 5.23
2024-06-30 $108k 24k 4.46
2024-03-31 $186k 24k 7.66

More positions owned by Bailard

Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus 2000 Val Etf (IWN)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Vanguard Index Fds Total Stk Mkt (VTI)
Gilead Sciences (GILD)
Ishares Tr Calif Mun Bd Etf (CMF)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Bailard

Top funds holding Inozyme Pharma

Adage Capital Partners GP
Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Affinity Asset Advisors
Rock Springs Capital Management
BlackRock
Vanguard Group
NEA Management Company
Eventide Asset Management
Millennium Management
FMR
Samsara BioCapital
Saturn V Capital Management
Sphera Funds Management
Geode Capital Management

View all funds holding Inozyme Pharma